Dr. Prashant K. Joshi
Overview
Prashant Joshi is a Hematologist and an Oncologist in Oak Lawn, Illinois. Dr. Joshi is rated as an Experienced provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Pleuropulmonary Blastoma, Schnitzler Syndrome, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Breast Cancer.
His clinical research consists of co-authoring 1 peer reviewed article. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- MEDICARE MAPD
- OTHER MEDICARE
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- MEDICARE MAPD
- MEDICARE SNP
Locations
4440 W 95th St 8th Fl, Oak Lawn, IL 60453
Chicago, IL 60617
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
David Vanderweele is a Hematologist and an Oncologist in Chicago, Illinois. Dr. Vanderweele has been practicing medicine for over 19 years and is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Non-Muscle Invasive Bladder Cancer, Orchiectomy, and Prostatectomy.
The University Of Chicago
Russell Szmulewitz is a Hematologist Oncology specialist and a Hematologist in Chicago, Illinois. Dr. Szmulewitz is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Renal Cell Carcinoma (RCC), Prostatectomy, and Orchiectomy. Dr. Szmulewitz is currently accepting new patients.
Edward Schaeffer is an Oncologist in Chicago, Illinois. Dr. Schaeffer has been practicing medicine for over 25 years and is rated as a Distinguished provider by MediFind in the treatment of Familial Prostate Cancer. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Ureteroscopy.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Breast CancerDr. Joshi isAdvanced. Learn about Breast Cancer.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Pleuropulmonary BlastomaDr. Joshi isAdvanced. Learn about Pleuropulmonary Blastoma.
- Schnitzler SyndromeDr. Joshi isAdvanced. Learn about Schnitzler Syndrome.
- Experienced
- Adrenocortical CarcinomaDr. Joshi isExperienced. Learn about Adrenocortical Carcinoma.
- Adult Soft Tissue SarcomaDr. Joshi isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Joshi isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung Cancer
- AnemiaDr. Joshi isExperienced. Learn about Anemia.
- AngiosarcomaDr. Joshi isExperienced. Learn about Angiosarcoma.